期刊文献+

Survivin在人非小细胞肺癌中的表达及其与VEGF表达的相关性 被引量:1

Expression of Survivin and its Correlation with VEGF in Non-small Cell Lung Cancer
原文传递
导出
摘要 目的:探讨Survivin在人非小细胞肺癌组织中表达、临床意义及其与VEGF表达的相关性。方法:采用免疫组织化学(Envision二步法)检测Survivin和VEGF在116例肺鳞癌、腺癌组织及15例肺良性病变组织中的表达情况。结果:Survivin、VEGF的阳性率分别为62.1%(72/116)、72.4%(84/116),显著高于肺良性病变组织的0(0/15)、13.3%(2/15);Survivin表达与非小细胞肺癌的低分化(P<0.05)、淋巴结转移呈正相关(P<0.05),与患者预后负相关(P<0.05);VEGF的表达与肺癌组织的分化程度、TNM分期及淋巴结转移均有关(P<0.05);并且Survivin表达与VEGF表达呈正相关(P<0.05)。结论:Survivin有望成为肺癌诊断和基因治疗的新靶点。 Objective: To investigate the expression of survivin and its correlation with VEGF in non-small cell lung cancer.Methods: The expression of survivin and VEGF were examined by using immunohistochemica1 staining(Envision two step method.Results: The positive expression rate of survivin and VEGF in NACLC and BPD was 62.1%(72/116),72.4 %(84/116)respectively,which was obviously higher than that in BPD.The expression of survivin was associated with the poor differentiation(P0.05) and lymph node metastasis(P0.05) respectively.However,it was negative correlated with the prognosis;The expression of VEGF was associated with the poor differentiation,TNM state and lymph node metastasis of lung cancer respective1y(P0.05).Besides,The expressions of surviving were corre1ated with VEGF each(P0.05).Condusion: Survivin gene may be identified as a defining diagnostic marker and a potential therapeutic target.
出处 《现代生物医学进展》 CAS 2011年第24期4864-4867,共4页 Progress in Modern Biomedicine
关键词 非小细胞肺癌 SURVIVIN VEGF 免疫组织化学 NSCLC Survivin VEGF Immunohistochemistry
  • 相关文献

参考文献15

  • 1Talvensaari MA, Paakko P, Hoyhtya M, et al. Matrix metallo-pro- teinase immunoreactive protein: a marker of aggressiveness in breast carcinoma [J]. Cancer, 1998,83 (6) : 1153-1162.
  • 2Ikeguchi M, Sakatani T, Ueta T, et al. Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squa-mous cell carcinoma [J]. JCP, 2002, 55 (2) :121-126.
  • 3Tryggvason K, Hoyhtya M, Salo T. Proteolytic degradation of extra- cel-lular matrix in tumor invasion [J]. Biochin Biophys Acta, 1987, 907(3) :191-217.
  • 4Montcourrier P, Mangeat PH, Salazar G, et al. Cathepsin D in breast cancer cells can digest extracellular matrix in large vesicles [J]. Cancer Res, 1990,50(18) :6045-6054.
  • 5Ryan BM, O'Donovan N, Duffy MJ. Survivin: a new target for an- ti-cancer therapy[J]. Cancer Treat Rev, 2009, 35(7):553-562.
  • 6Botelho F, Pina F, Lunet N. VEGF and prostatic cancer: a systematic review[J]. Eur J Cancer Prev. 2010 Sep;19(5):385-392.
  • 7Sinicrope FA, Ruan SB, Cleary KR, et al. Bc122 and p53 oncop rotein- expression during colorectal tumorigenesis [J]. Cancer Res, 1995, 55 (2) : 237-241.
  • 8Vlom M, Koomagi R, Mmattren J. Prognostic value of vasculaa en- dothelial growth and its receptor Flt-lin squamous cell lung cancer [J]. Int.J cancer,1997,74(1):64-68.
  • 9Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, sur- vivin,expressed in cancer and lymphoma [J], Nat Med,1997,3 (8): 917-921.
  • 10Ikegnchi M, Ueda T, Sakatani T, et al. Expresion of survivin messen- ger RNA correlates with poor prognosis in patients with hepatoceUu- larcar'cinoma[J]. Diagn Mol Pathol, 2002, 11(1): 33-34.

同被引文献11

  • 1魏玉萍,白海,孙延庆,刘琳.低剂量辐射对骨髓间充质干细胞survivin基因表达的影响[J].宁夏医科大学学报,2013,35(5):497-501. 被引量:2
  • 2Zhao H, Bauzon F, Fu H, et al. Skp2 deletion unmasks a p27 safeguard that blocks tumorigenesis in the absence of pRb and p53 tumor suppressorsEJ. Cancer Ce11,2013,24 (5) :645 -659.
  • 3KuUmann MK,Grubbauer C,Goetsch K, et al. The p27-Skp2 axis mediates glucocorticoid-induced cell cycle arrest in T- lymphoma cells[ J]. Cell Cycle,2013,12(16) :2 625 -2 635.
  • 4Sorbye SW,Kilvaer TK,alkov A,et al. Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas [ J ]. BMC Clin Pathol,2013 ,13 :9.
  • 5Lv A, Li Z, Tian X, et al. SKP2 high expression, KIT exon 11 deletions, and gastrointestinal bleeding as predictors of poor prognosis in primary gastrointestinal stromal tumors [J]. PLoS One,2013,8(5):e62 951.
  • 6Liu J ,Wei XL,Huang WH, et al. Cytoplasmic Skp2 expres- sion is associated with p-Aktl and predicts poor prognosis in human breast carcinomas[J]. PLoS One,2012,7(12) : e52 675.
  • 7Wei Z,Jiang X,Liu F,et al. Downregulation of Skp2 inhib- its the growth and metastasis of gastric cancer cells in vitro and in vivo[ J]. Tumour Biol,2013,34 ( 1 ) :181 - 192.
  • 8李香梅,李男,王新,李莹,肖建英,朱艳凌.Skp2与恶性肿瘤关系的研究进展[J].辽宁医学院学报,2008,29(2):180-182. 被引量:3
  • 9梁运宁,王永岗.非小细胞肺癌的手术治疗现状[J].广西医学,2008,30(10):1524-1526. 被引量:13
  • 10陈万青,张思维,邹小农.中国肺癌发病死亡的估计和流行趋势研究[J].中国肺癌杂志,2010,13(5):488-493. 被引量:516

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部